Navigation Links
NIH expands national consortium dedicated to transforming clinical and translational research
Date:5/29/2008

rsity of Colorado Denver (Aurora, Colo.)

The University of North Carolina at Chapel Hill (Chapel Hill, N.C.)

The University of Texas Health Science Center at San Antonio (San Antonio)

The University of Utah (Salt Lake City)

These 14 academic health centers join 24 others announced in 2006 and 2007. Total funding for these new awards is $533 million over five years. The 2008 CTSA grants expand state representation in the consortium to Alabama, Colorado, Indiana, Massachusetts, and Utah. They also support pediatric research at 13 dedicated childrens hospitals; expand research in genetics and genomics; enhance research in behavioral immunology and infection risk; and increase outreach into local communities.

As the CTSA consortium expands across the nation, the NIH is elevating clinical and translational research from a single research enterprise to a network of exceptional collaborations that will translate new knowledge into tangible benefits for the American people by bringing together diverse perspectives and expertise leading to new prevention strategies and clinical treatments, said NCRR Director Barbara M. Alving, M.D.

Since its launch in 2006, the consortium has been:

  • training researchers in the complexities of clinical and translational research through nationally recognized degree-granting programs;

  • leveraging CTSA resources to expand research and training opportunities in underserved states and communities;

  • assembling interdisciplinary teams that include but are not limited to basic scientists, biologists, clinical researchers, dentists, veterinarians, nurses, pharmacists, biomedical engineers, and geneticists;

  • partnering with researchers at minority institutions to enhance outreach to underserved populations, local community and advocacy organizations, and health care providers;


    '/>"/>

Contact: Joyce McDonald
Info@ncrr.nih.gov
301-435-0888
NIH/National Center for Research Resources
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Ossur -- leading orthopedic pioneer - expands network to Asia
2. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
3. DHS Expands Biometrics-at-Sea Program to the Florida Straits
4. Springer expands publishing partnership with the Biomedical Engineering Society
5. Science expands Science Signaling, featuring research related to medical advances, and more
6. bioMETRX Expands Engineering and Manufacturing Capabilities
7. Wolves find happy hunting grounds in Yellowstone National Park
8. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
9. ESMO International Symposium on Immunology
10. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
11. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...mes to investment in energy efficient technologies...esearch Council (EPSRC) Chief Executive Dave Delpy...ineering research has already brought us fuel cell...e investment is needed to develop the capabilities...on emission targets by 2020 and limit the impact o...
(Date:12/2/2009)...strengthen the evidence that people who smoke ciga...d risk for developing colorectal cancer, even afte...ides one more reason not to smoke, or to quit as s...un, M.D., M.S., vice president emeritus, epidemiol...er Society. "Colorectal cancer should be added to ...
(Date:12/2/2009)...er-free status did not prompt people participating...cancer screening program to pick up their cigarett...n Cancer Epidemiology, Biomarkers & Prevention , ...esearch. The December issue contains a special foc...espread concern in the lung screening community th...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2Universal Health Services Inc Announces Dividend 51192 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 2
...ose of chemotherapy drugs to specific cancer cells... may one day be possible thanks to a nanoscale dru... the U.S. Department of Energy,s Ames Laboratory. ...spheres to carry drugs inside living cells, Ames L... methods to control whether or not the particle de...
...ene-coated gold particles protect mice against a p...ers at UT Southwestern Medical Center have found. ...roducing the specific protein ?called amyloid-beta...odies and greatly reduce the protein,s build-up in...ans is a hallmark of Alzheimer,s disease. , "The ...
...hool of Medicine researchers have identified the p...e first line of defense against invading pathogens...site this week and will be published in a future i...re body is formed in the skin by a group of cells ...gens present in the skin and transport them to lym...
Other Biology News:Cellular scale drug delivery from the inside out 2Cellular scale drug delivery from the inside out 3DNA gene vaccine protects against harmful protein of Alzheimer's disease 2Source of crucial immune cell in the skin discovered 2
(Date:12/2/2009)... CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolyti...SX:ONC; NASDAQ: ONCY ) announced today that in con...g, the underwriters have exercised in full their o...37,500 units. Each unit is comprised of one common... and was sold at a price of US$3.00 per unit. Each...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 Gamida Cell an...reclinical (animal study) safety and,efficacy of a...om Weill,Cornell Medical College and Gamida Cell. ...anemias such as Cooley,s Anemia. , Gamida Cell... ex vivo,populations of stem/progenitor cells. The...
(Date:12/2/2009)... CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zen...y"), a global biopharmaceutical company focused on...hat the U.S. Food and Drug Administration (FDA) ha... PI3K/Akt pathway inhibitor compound, perifosine (...y multiple myeloma. Keryx Biopharmaceuticals, Inc....
(Date:12/1/2009)... Dr. Kerry Solomon announced that he ...nched his redesigned website at www.DrKerrySolomo...Group. Dr. Solomon is a proven LASIK, lens implan...sionally recognized for his substantial contributi... a member of Trusted LASIK Surgeons, which screens...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
..., March 13 /PRNewswire-FirstCall/ -- DOR BioPhar...mpany) announced today that it has appointed Brian...d Chief Medical Officer. Dr. Hamilton is a recogni...ally active steroids as well as in Graft-versus-Ho...shed career of more than 25 years in both academia...
... Some of the world,s most respected e...security questions during a daylong gathering in H...eater Houston Partnership once again takes center ...hosting "America,s Energy Future: Assessing O... Houston (PRWEB) March 13, 2009 -- Pres...
... N.J., March 12 Schering-Plough Corporation (NYSE...arnings results for the 2009 first quarter on Tues...that day, Schering-Plough will conduct a conferenc...r. Fred Hassan, Schering-Plough,s chairman and CE...onference call. , , To listen live to the call, ...
Other Biology Technology:DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 2DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 3DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 4DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 5Greater Houston Partnership to Lead Energy Security Discussion 2
Feline serum from Equitech-Bio
Donor feline Serum - 500mL from Biomeda Corporation
Paraffin Tissue Section Panel - Monkey (Simian) Normal Tissue, Multi-tissue I from BioChain
Mouse Anti-Rabbit ryanodine receptor, skeletal Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: